Abstract The Leiden mutation in the coagulation factor V (F5) gene associated with preeclampsia in Caucasians has not been found in Japanese populations. We examined the association of 20 missense polymorphisms in the F5 gene in 133 pregnant Japanese women with preeclampsia and in 224 unrelated, healthy, pregnant Japanese women. Among nine polymorphisms identified in the subjects, the M385T and R485K polymorphisms were associated with preeclampsia (P ϭ 0.05 and P ϭ 0.02, respectively). Haplotype analysis indicated that the R485K polymorphism is truly associated with preeclampsia, whereas the association of the M385T polymorphism is due to linkage disequilibrium. Taken together with reports that the R485 allele yields poor factor V function in comparison with that of the K485 allele and that the F5 Leiden mutation is associated with preeclampsia in Caucasian populations, the findings of the present study suggest that the F5 gene is associated with preeclampsia in pregnant Japanese women.
Introduction
Preeclampsia, which is diagnosed by increased blood pressure together with proteinuria, is a pregnancy-specific syndrome that occurs in 3%-5% of pregnancies (Roberts and Cooper 2001) and is a leading cause of maternal and perinatal mortality. Associations of preeclampsia with polymorphisms in the angiotensinogen (AGT) (Kobashi et al. 1999a; Ward et al. 1993) , coagulation factor V (F5) (DizonTownson et al. 1996; Grandone et al. 1997) , lipoprotein lipase (LPL) (Hubel et al. 1999) , glutathione S-transferase (GSTP1) (Zusterzeel et al. 2000) , apolipoprotein E (APOE) (Nagy et al. 1998a) , and endothelial nitric oxide synthase (eNOS) (Yoshimura et al. 2000) genes have been reported. We previously reported that preeclampsia is associated with polymorphisms in the 5,10-methylenetetrahydrofolate reductase (MTHFR) (Sohda et al. 1997 ) and plasminogen activator inhibitor 1 (PAI1) genes.
Human coagulation factor V (FV) circulates in the plasma as a 330-kDa single chain glycoprotein. Organization of the functional domains (A1-A2-B-A3-C1-C2) is similar to that of factor VIII. FV is activated by selective proteolytic cleavage that removes the large B domain, and FVa is inactivated by activated protein C (APC) (Rosing and Tans 1997) . Association between preeclampsia and the Leiden mutation in F5 has been reported several times (Dizon-Townson et al. 1996; Grandone et al. 1997; Mimuro et al. 1998; Nagy et al. 1998b; Rigo et al. 2000) . The Leiden mutation is a single base mutation in the F5 gene that results in an amino acid substitution (R506Q) at a predominant APC-cleavage site and is a risk factor for familial venous thrombosis (Rosing and Tans 1997) . Because the Leiden mutation has not been identified in Japanese individuals (Kobashi et al. 1999b; Ohnishi et al. 2000; Ozawa et al. 1996; Rees et al. 1995; Ro et al. 1999) , possible association between preeclampsia and the Leiden mutation in Japanese women cannot be investigated. However, we previously found an association between the R485K polymorphism in F5 and preeclampsia in a Japanese population (Watanabe et al. 2001) . Although our findings support association between the F5 gene and preeclampsia, it is possible that the observed association reflects linkage disequilibrium between the polymorphism and the true susceptibility locus. To investigate this possibility, we examined possible associations between 20 nonsynonymous polymorphisms in the F5 gene and preeclampsia.
Subjects and methods

Samples
Peripheral blood samples were obtained from 133 women with preeclampsia and from 224 healthy pregnant volunteers. The subjects were unrelated Japanese. Samples were collected at the University of Tsukuba Hospital, Japan. The diagnosis of preeclampsia was based on the criteria of the American College of Obstetricians and Gynecologists (1996) . None of the subjects had a history of hypertension or renal disease. The age-matched pregnant controls were apparently healthy and without hypertension or proteinuria. None of the control subjects had experienced preeclampsia during a pregnancy. All patients and controls were described in a previous report (Watanabe et al. 2001) . The Ethics Committee of Tsukuba University approved the research protocol, and written informed consent was obtained from each subject.
Methods
Genomic DNA was isolated from peripheral blood leukocytes by phenol extraction. Missense mutations in the F5 gene were identified from three databases (HGBASE, http://www.hgbase.de/; dbSNP, http:// www.ncbi.nlm.nih.gov/SNP/; and the JSNP database, http:// snp.ims.u-tokyo.ac.jp/index.html) ( Table 1 ). The genotypes of the missense mutations were determined by restriction fragment length polymorphism (RFLP) analysis and direct sequence analysis after polymerase chain reaction (PCR) amplification (Table 2 ).
Statistical analysis
Deviation from Hardy-Weinberg equilibrium and differences in genotype and allele distributions between groups were evaluated by -squared test and Fisher's exact test. We Table 2 . PCR primers and genotyping method
5Ј-ATTTGGCTTTCAGATTTTTG RFLP (EcoR V) 5Ј-ATGTTCAATTCTAGTAGATA a PCR, polymerase chain reaction; RFLP, restriction fragment length polymorphism a Mismatch primers; mismatch is underlined 
Results
There were 20 missense mutations in the F5 gene in the three databases searched in the present study (Table 1) . Nine of these polymorphisms were found among the study participants. In addition, we detected one novel silent mutation (4028C/T, S1285S). Genotype and allele distributions in patients and controls are shown in Table 3 . The K830R, H837R, and E897K polymorphisms were in complete linkage disequilibrium; therefore, these polymorphisms are shown together in Table 3 . The results of linkage disequilibrium tests are shown in Table 4 . The H837R and E897K polymorphisms were excluded because of complete linkage disequilibrium with the K830R polymorphism. With the exception of the L1302I polymorphism, all the polymorphisms were in significant linkage disequilibrium (P Ͻ 0.05).
Genotype frequencies of polymorphisms in the control subjects did not differ significantly from those predicted by Hardy-Weinberg equilibrium. A statistically significant difference between the patients and the control subjects was observed in the allele frequencies of the R485K polymorphism (P ϭ 0.02), and a difference between the patients and the control subjects in the allele frequencies of the M385T polymorphism was marginally significant (P ϭ 0.05).
Because the M385T and R485K polymorphisms were in linkage disequilibrium, an association of preeclampsia with one polymorphism could actually reflect association with the other. To evaluate this possibility, we carried out haplotype analysis of these two polymorphisms (Table 5) . Overall haplotype distributions differed significantly between the patients and the control subjects (P ϭ 0.003). Both the T-K and M-K haplotypes were observed more frequently in the patient group than in the control group. However, opposite directions were observed between the M-K and M-R haplotypes, indicating that the M allele of the M385T polymorphism is not likely to be associated with preeclampsia.
Discussion
In the present study, we examined the association with preeclampsia of all nonsynonymous polymorphisms in the F5 gene listed in public single-nucleotide polymorphism databases and found potential associations for the M385T and R485K polymorphisms. Because these two polymorphisms are in linkage disequilibrium with each other, it is possible that the association of one polymorphism really Watanabe et al. 2001 reflects that of the other. With haplotype analysis, we observed the T-K and M-K haplotypes more frequently in preeclamptic patients than in control subjects. Our findings suggest that the association of the M385T polymorphism most likely reflects the true association of the R485K polymorphism, and, therefore, we concluded that the R485K polymorphism is associated with preeclampsia in our patients. The M385T polymorphism is located in the region encoding the heavy chain of FV, which is involved directly in the generation of thrombin and the inactivation of FVa by APC (de Visser et al. 2000) , and it was first reported by de Visser et al. (2000) . They reported that the T385 allele is not associated with increased risk of venous thrombosis and that this variation is not conserved across species. These findings support our conclusion that the M385T polymorphism is not associated directly with preeclampsia.
The F5 R485K polymorphism was first reported by Gandrille et al. (1995) . There are differences in the frequencies of the R485K alleles among races (Helley et al. 1997) ; the frequency of the K485 allele is low in Caucasians and high in Asians (Helley et al. 1997; Hiyoshi et al. 1998 ). An association of the R485K polymorphism with thrombotic and cardiovascular diseases has been reported (Hiyoshi et al. 1998; Le et al. 2000) . Hiyoshi et al. (1998) reported that the K485 allele is a risk factor for thrombosis in a Thai population, and Le et al. (2000) reported that the K485 allele confers increased risk for coronary artery disease in a Chinese population. In the present study, the frequency of the K485 allele was higher in the preeclampsia patients than in the control group (75.9% vs. 67.4%, P ϭ 0.02). The R485K polymorphism is located in the alpha-loop of the A2 domain, which is close to the Leiden mutation (Le et al. 2000) . The R485 allele is conserved in cows, pigs, and mice. A significant association between poor response to normalized APC and the R485K polymorphisms in normal populations has not been found (Gandrille et al. 1995; Helley et al. 1997) . However, Le et al. (2000) reported that the K485 allele is associated with reduced response to normalized APC in patients with coronary artery disease but not in control subjects. Thus, it is possible that the R485K polymorphism differs functionally with respect to pathological conditions of the cardiovascular system. In the present study, the K485 allele was associated with preeclampsia, indicating that activation of intravascular coagulation is associated with preeclampsia. It is possible that other polymorphism(s) in linkage disequilibrium with R485K may be associated directly with preeclampsia. One limitation of our study was that we did not examine polymorphisms not listed in the public databases.
In conclusion, our data, taken together with reports of association between the F5 Leiden mutation and preec-lampsia in Caucasian populations suggest that the F5 gene is associated with preeclampsia.
